Bloomberg Law
April 16, 2020, 5:31 PM

Novartis Must Face Whistleblower’s False Claims Retaliation Suit

Daniel Seiden
Daniel Seiden

A whistleblower adequately alleged that Novartis Pharmaceutical Corp. fired him for calling attention to an alleged drug kickback scheme, in violation of the False Claims Act, a New Jersey federal court said Thursday.

Former Novartis account director Joseph Perri raised a valid FCA retaliation claim by asserting that he lost his job, despite receiving excellent performance reviews, because he complained about the scheme to his supervisor, Judge Kevin McNulty of the U.S. District Court for the District of New Jersey said.

That Perri’s severance package was accompanied by a demand that he waive any whistleblower claim is also suggestive, though ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.